Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.

Xia, Huivan den Hof, SusanCobelens, FrankZhou, YangZhao, BingWang, ShengfenZhao, Yanlin2020-04-052020-04-052020-01-071471-23343191087810.1186/s12879-020-4758-9http://hdl.handle.net/10029/623724enMultidrug-resistant tuberculosisPyrazinamideResistancepncAValue of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China.ArticleBMC Infect Dis 2020; 20(1):19